Get started

IPO

$BABA BABA staging a strong comeback like FB in 2012News from Alibaba ($BABA) spiked the stock higher. Some wonder if this is the time to short after all the stock has be up +140% since it's bottom back in 2016. However since the double bottom was put in last year, $BABA has been showing great signs of a stock ready to become the next big IPO that many will say in the future, "if only I had held on to my shares of ALIBABA back in 2017 when it first began going on. This is history in the market. Unless the stock closes below $120 in the next few months, this is a long term stock to add to any portfolio
NYSE:BABALong
by Rightsidetrading
MSTX on the eve of a pivotal Merger CC: CHART ANALYSYSMSTX (Mast therapeutics) shareholders have been overdue for some good news after the SEP data disaster wiped out nearly 80% of stock value dropping it from the .60s to a range of .10-15. VAPOLAXOMER* was a novel technology designed by MSTX to help ease sufferers of sickle cell anemia that ultimately was proven ineffective and was abandoned. Left with only AIR001, an inhaled sodium nitrite solution to treat heart failure with preserved ejection fraction (HFpEF) currently in Phase 2 development, MSTX had essentially become a shell with no substantial news until Q1'18. Now MAST and SAVARA (a private company) have signed a DEFINITIVE MERGER AGREEMENT in effort to form a company focused on the development of novel inhalation therapies. This reverse merger is essentially serving as an IPO for SAVARA and is likely to cause a nice pop in MSTX pps and a small P&D type move that could easily see pps of .33-57ish, potential gain % in the 200 which makes me a short term LONG but ultimately neutral. Mast and Savara will hold the conference call TODAY Monday, January 9, 2017, at 8:30 a.m. EST / 5:30 a.m. PST to discuss the transaction. To access the conference call dial (855) 239-3120 from the U.S, (855) 669-9657 from Canada, and (412) 542-4127 from outside the U.S. and request the "Mast-Savara Conference Call". A live webcast of the conference call will be available from the Investors section of Mast's website at www.masttherapeutics.com SIMPLE CHART ANALYSIS SUP: backsliding is not likely to happen but if so look for a entry op @.0925-975 REALISTICALLY .095 should be the bounce point RES: look for selling in the following zones WEAK @.107-12, MID @.13-15, STRONG @.17-26 REALISTICALLY .24 is the RES to look for Notable RES: W MBB @.1836/EMA50 @.2634 D EMAs .1175/17/25 -woof
M
by AutonomousEin